Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$UroGen Pharma Ltd (URGN.US)$ Following Pre-NDA Meeting With...

$UroGen Pharma Ltd(URGN.US)$ Following Pre-NDA Meeting With The FDA, UroGen Announces Rolling NDA Submission For UGN-102 For Low-grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer To Begin January 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
3835 Views
Comment
Sign in to post a comment
    1897Followers
    30Following
    23KVisitors
    Follow